With a market cap of has a large market cap size. Mylan N.V. (NASDAQ: MYL) has been on the stock market since its IPO date on the 12/18/1987. Mylan N.V. is in the Drugs – Generic industry and Healthcare sector. Average volume for Mylan N.V., is 4952.25, and so far today it has a volume of 3108900. Performance year to date since the 12/18/1987 is -17.61%.
To help you determine whether Mylan N.V. is undervalued the following values will help you decide. P/E is 28.48 and forward P/E is 7.6. PEG perhaps more useful shows that Mylan N.V. has a value for PEG of 2.04. P/S ratio is 2.28 and the P/B ratio is 2.12. The P/Cash and P/Free cash flow is 18.53 and 15.27 respectively.
At the current price Mylan N.V. is trading at, 44.55 (0.02% today), Mylan N.V. has a dividend yield of *TBA, and this is covered by a payout ratio of 0.00%. Earnings per share (EPS) is 1.56, and this is looking to grow in the next year to 18.48% after growing -31.50% this past year. EPS growth quarter over quarter is -78.60%, and 17.10% for sales growth quarter over quarter.
The number of shares outstanding is 498.78, and the number of shares float is 412.26. The senior management bring insider ownership to 0.70%, and institutional ownership is at 71.00%. The float short is 6.27%, with the short ratio at a value of 5.22. Management has seen a return on assets of 3.60%, and also a return on investment of 8.20%.
The ability for Mylan N.V., to deal with debt, means it current ratio is 1.7, and quick ratio is 1.1. Long term debt/equity is 0.62 and total debt/equity is 0.73. In terms of margins, Mylan N.V. has a gross margin of 44.50%, with its operating margin at 14.60%, and Mylan N.V. has a profit margin of 8.30%.
The 52 week high is -38.96%, with 18.52% being its 52 week low. The 20 day simple moving average is 3.28% and the 200 day simple moving average is -4.47%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.